This induces more profound and long-term immunosuppression in these patients; for example, alkylate drugs, such as bendamustine, generate a prolonged CD4 lymphopenia which decreases up to 6 months after receiving the last dose and does not recover until 7–9 months after the end of treatment [67,68,69,70]. Here, CD4 is linked to lymphopenia.